Ads
related to: Fda and ALS
Search results
Research confirms the therapeutic potential of MDMA, ketamine, and psilocybin to help people with...
American Psychological Association· 5 days agoM., et al., JAMA, Vol. 314, No. 5, 2015). While small studies in recent years started to show...
STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML
MedPage Today· 6 days agoThe STAMP inhibitor asciminib (Scemblix) had a statistically superior response rate compared with...
Health care providers want this information before prescribing the HIV prevention, PrEP, to...
Medical Xpress· 2 days agoHIV infections among adolescents and young adults continue to be at high levels, with Americans...
Scientists find new method to enhance efficacy of bispecific antibodies for solid tumors
Medical Xpress· 5 days agoResearchers have revealed a new method to significantly enhance the efficacy of bispecific antibody...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 2 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, presented updated clinical ...
BSC, squatters, Bushwackers: Down in Alabama
Birmingham News· 2 days agoBirmingham-Southern’s baseball season finally came to an end on Sunday, but it outlasted the existence of the school by two days. Tell that to a bunch of...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPatients had received a median of three prior systemic anti-cancer regimens, including prior platinum-based chemotherapy, prior anti-PD1/L1 therapy, and prior epidermal growth factor receptor ...
DiviTum(R) TKa Results to be Presented at ASCO the World’s Largest Cancer Conference
Digital Journal· 6 days agoLink to study: 10.1200/JCO.2024.42.16_suppl.1028 Ref. J. Albanell, et al, J Clin Oncol 42, 2024 (suppl 16; abstr 1028) Contact Anders Rylander, CEO...patients." Biovica collaborates ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoMELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as Non-Executive
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 6 days agoOncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that favorable data regarding its lead product VitaGraft™ Kidney was published in the New England Journal ...
Ads
related to: Fda and ALS
